Lipocine (STU:2VT0) Cyclically Adjusted Book per Share: €5.38 (As of Mar. 2026)


STU:2VT0 Lipocine Inc STU:2VT0
50 GF Score
Price €3.94
GF Value €2.90
! 4 Warning Signs
View Full Analysis

What is Lipocine Cyclically Adjusted Book per Share?

Lipocine STU:2VT0 50 Cyclically Adjusted Book per Share is €5.38 as of Mar. 2026. GuruFocus rates STU:2VT0 with a GF Score™ of 50/100 and a GF Value™ of €2.90. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lipocine's adjusted book value per share for the three months ended in Mar. 2026 was €2.642. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.38 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Lipocine's average Cyclically Adjusted Book Growth Rate was -31.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lipocine was -7.90% per year. The lowest was -20.40% per year. And the median was -14.15% per year.

As of today (2026-07-01), Lipocine's current stock price is €3.944. Lipocine's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €5.38. Lipocine's Cyclically Adjusted PB Ratio of today is 0.73.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lipocine was 1.48. The lowest was 0.10. And the median was 0.26.


Lipocine  (STU:2VT0) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lipocine's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.944/5.38
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lipocine was 1.48. The lowest was 0.10. And the median was 0.26.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lipocine Cyclically Adjusted Book per Share Related Terms


Lipocine Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Lipocine's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipocine Cyclically Adjusted Book per Share Chart

Lipocine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.71 21.40 30.15 13.38 5.77

Lipocine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.60 17.94 18.07 5.77 5.38

STU:2VT0 vs NCEL, PTN, ALLR: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Lipocine's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipocine Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipocine's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lipocine's Cyclically Adjusted PB Ratio falls into.


STU:2VT0
50GF Score
Lipocine Inc STU:2VT0
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lipocine Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lipocine's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.642/330.2130*330.2130
=2.642

Current CPI (Mar. 2026) = 330.2130.

Lipocine Quarterly Data

Book Value per Share CPI Adj_Book
201606 25.493 241.018 34.927
201609 23.214 241.428 31.751
201612 22.711 241.432 31.062
201703 20.530 243.801 27.807
201706 18.482 244.955 24.915
201709 16.006 246.819 21.414
201712 12.820 246.524 17.172
201803 10.808 249.554 14.301
201806 9.496 251.989 12.444
201809 8.032 252.439 10.507
201812 6.488 251.233 8.528
201903 7.683 254.202 9.980
201906 5.995 256.143 7.729
201909 4.630 256.759 5.955
201912 2.555 256.974 3.283
202003 2.107 258.115 2.696
202006 3.219 257.797 4.123
202009 3.188 260.280 4.045
202012 3.061 260.474 3.881
202103 6.856 264.877 8.547
202106 5.712 271.696 6.942
202109 5.369 274.310 6.463
202112 7.765 278.802 9.197
202203 7.397 287.504 8.496
202206 7.249 296.311 8.078
202209 7.303 296.808 8.125
202212 6.460 296.797 7.187
202303 5.733 301.836 6.272
202306 5.034 305.109 5.448
202309 3.963 307.789 4.252
202312 3.514 306.746 3.783
202403 4.146 312.332 4.383
202406 3.684 314.175 3.872
202409 3.221 315.301 3.373
202412 3.750 315.605 3.924
202503 3.320 319.799 3.428
202506 2.763 322.561 2.829
202509 2.223 324.800 2.260
202512 2.008 324.054 2.046
202603 2.642 330.213 2.642

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €5.38 mean?
Lipocine (STU:2VT0) has a Cyclically Adjusted Book per Share of €5.38 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lipocine and its competitors.
Is Lipocine's Cyclically Adjusted Book per Share too high?
Lipocine's current Cyclically Adjusted Book per Share is €5.38. Overall, Lipocine has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Lipocine's Cyclically Adjusted Book per Share compare to NCEL and PTN?
Lipocine's Cyclically Adjusted Book per Share of €5.38 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lipocine and its competitors. Lipocine's current Cyclically Adjusted Book per Share is €5.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipocine stock overvalued right now?
Lipocine (STU:2VT0) has a current Cyclically Adjusted Book per Share of €5.38. The stock's GF Value™ is €2.90, compared to a current price of €3.94 — trading 36% above its estimated fair value. The current Cyclically Adjusted Book per Share is €5.38. Lipocine's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Lipocine (STU:2VT0), the current Cyclically Adjusted Book per Share is €5.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lipocine (STU:2VT0) Overvalued in 2026?

Based on GuruFocus' analysis, Lipocine stock appears to be overvalued. The current stock price of €3.94 is trading 36% above its estimated GF Value™ of €2.90.

Key valuation signals for STU:2VT0:

  • Cyclically Adjusted Book per Share: €5.38
  • GF Value™: €2.90 vs. price of €3.94 (36% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the STU:2VT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lipocine Business Description

Other Exchanges LPCN:USA
Address 675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
50GF Score

Get the complete analysis for STU:2VT0

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.94
Price
€2.90
GF Value